The AKAP6 antibody is a tool used to detect A-kinase anchoring protein 6 (AKAP6), a scaffold protein critical for organizing signaling complexes in cells. AKAP6. also known as mAKAP, belongs to the AKAP family, which tethers protein kinase A (PKA) to specific subcellular locations, ensuring spatial and temporal regulation of cAMP/PKA signaling. Primarily expressed in cardiac and skeletal muscle, AKAP6 localizes to the nuclear envelope and sarcoplasmic reticulum, where it assembles multi-protein complexes involving PKA, phosphodiesterases, and other kinases (e.g., ERK5). These complexes modulate cardiac hypertrophy, ion channel function, and calcium handling, making AKAP6 vital for maintaining heart physiology. Dysregulation of AKAP6 has been implicated in cardiovascular diseases, including arrhythmias and heart failure, as well as certain cancers. The AKAP6 antibody is widely used in research to investigate its role in signaling pathways, protein interactions, and disease mechanisms. It is commonly validated via techniques like Western blotting, immunofluorescence, and immunohistochemistry. Specificity is confirmed using knockout controls or siRNA-treated samples. Commercial AKAP6 antibodies are available as polyclonal or monoclonal forms, often targeting specific domains (e.g., N-terminal regions). Researchers rely on this antibody to explore AKAP6's dual roles as a signaling hub and potential therapeutic target.